ILMN vs NTRA
Illumina, Inc. and Natera, Inc., both Healthcare
Natera, Inc. is the larger company at $33B against $25B. Over the past year NTRA returned +140% against +136% for ILMN. Ryufin's sector-relative Smart Score puts NTRA ahead, 10/10 against 7/10.
| Figure | ILMN | NTRA |
|---|---|---|
| Last close | $225 | $339 |
| Market cap | $25B | $33B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 42.0 | n/a |
| 1-year return | +136% | +140% |
| 5-year return | -53% | +201% |
| Ryufin Smart Scoresector-relative, 1–10 | 7/10 | 10/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Illumina, Inc.
Revenue of $1.2B in Q2 2026, net income $207M. Its largest reported line is United States And Canada, 54% of the disclosed total.
Natera, Inc.
Revenue of $753M in Q2 2026, net income null. Its largest reported line is US, 98% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.